After completing an undergraduate degree in Natural Sciences at the University of Cambridge in 2006, Karen became a research scientist at the Animal Health Trust, UK. During her time there, she completed a PhD in molecular microbiology and evolutionary genetics in partnership with the University of Cambridge and went on to hold a post-doctoral position. Her research focused on the fundamental biology of infectious diseases, outbreak analysis and the development of vaccines and diagnostic assays. In 2017, she left the lab to pursue a career in science communication. During her time at Technology Networks as senior scientific specialist, Karen coordinated and created a range of scientific content, tools and resources for the site, led interdepartmental projects and provided scientific support across the teams. Karen left Technology Networks in October 2025.
Education
Wine & Spirit Education Trust (WSET)
Awards & Certifications
National Finalist in Biotechnology Young Entrepreneur Scheme
Walter and Dorothy Plowright Memorial Prize for Young Researchers, 2nd
National Finalist in SET for Britain
Accreditations
Good Clinical Practice (GCP) trained
WSET Level 3 Award in Wines - Distinction recognised by Wine & Spirit Education Trust (WSET)
Natural Sciences, BA (Hons), MA recognised by University of Cambridge
Doctor of Philosophy (PhD) recognised by University of Cambridge
Member recognised by American Society for Microbiology
Member recognised by Microbiology Society
Member recognised by The Veterinary Research Club
Areas of Expertise
Got a Question for Karen Steward, PhD?
Get in touch using the contact form linked here and we'll get back to you shortly.
Lateral Flow Testing: Principles, Applications and Innovations
The Future of AI/ML in Liquid Chromatography
Key Trends and Technologies in Food Analysis
From Platform Engineering to Next-Generation Therapies: The ReiThera Story
“Every patient has the potential to eradicate their cancer within their own immune system”: New Frontiers in Cancer Vaccines
Inside Cambridge’s Collaborative Future: How journey Is Transforming the Lab Space Landscape
Building the Next Generation of Genetic Medicines With LNPs
Driving Innovation While Navigating Global Pressures: How One Life Science Company Is Evolving With the Market
A New Era in Drug Discovery Begins as FDA Embraces Human Models
